Xenon Pharmaceuticals Inc (XENE)
Operating Cash Flow Growth
-46.79%
TTM · Period ending:
XENE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-46.79%period ending
Latest reported-46.79%period ending
XENE TTM Cash from Operations YoY % (-102.29% → -46.79%)
Year-over-year change
High-resolution chart · PNG
XENE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -46.7893% | |
| -54.4316% | |
| -52.5935% | |
| -53.6757% | |
| -46.8661% | |
| -26.2745% | |
| -25.8651% | |
| -15.009% | |
| -19.7261% | |
| -37.3122% | |
| -47.645% | |
| -65.0241% | |
| -84.1437% | |
| -70.2017% | |
| -41.6218% | |
| -39.5794% | |
| -20.6199% | |
| -19.5321% | |
| -43.0182% | |
| -293.1139% | |
| -443.1013% | |
| -522.6483% | |
| -949.1493% | |
| 50.18% | |
| 71.6721% | |
| 74.3205% | |
| 86.6605% | |
| 7.8992% | |
| -30.9572% | |
| -15.3748% | |
| -20.88% | |
| -29.2266% | |
| -30.1256% | |
| -44.5952% | |
| -46.8084% | |
| -31.8407% | |
| -9.5148% | |
| -20.4743% | |
| -8.0871% | |
| -27.4372% | |
| -342.1087% | |
| -294.2329% | |
| -6,905.6391% | |
| -3,076.8362% | |
| -498.4516% | |
| -227.1186% | |
| 108.0072% | |
| -97.2166% | |
| -102.292% |